» Authors » Edouard Lamy

Edouard Lamy

Explore the profile of Edouard Lamy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 305
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Leroux P, Castera-Ducros C, Conreur L, Taleb S, Diack A, Cayez L, et al.
Ann Pharm Fr . 2025 Feb; PMID: 40015451
Objectives: High-Alert Medications represent a significant concern in clinical practice. The importance of raising awareness and training healthcare professionals appears essential for improving the quality and safety of care. Thus,...
2.
Lamy E, Orneto C, Ali O, Kireche L, Mathias F, Bouguergour C, et al.
Pharmaceuticals (Basel) . 2025 Feb; 18(2). PMID: 40006018
Little information is available on the stability and quality controls of compounded 40% dextrose gel required to ensure its safe use in the treatment and prevention of neonatal hypoglycemia. Whether...
3.
Curti C, dHuart E, Lamy E, Primas N, Fersing C, Bornet C, et al.
Am J Health Syst Pharm . 2024 Jul; 81(23):e770-e776. PMID: 39078107
Purpose: A leachable cyclic amide (caprolactam) can be found in normal saline (NS) and 5% dextrose in water (D5W) plastic bags widely used in clinical practice if they contain polyamide...
4.
Camy C, Grunewald T, Lamy E, Roseren F, Caumes M, Fovet T, et al.
Bone Rep . 2024 Jan; 20:101734. PMID: 38292933
The fibrocartilaginous tendon enthesis, i.e. the site where a tendon is attached to bone through a fibrocartilaginous tissue, is considered as a functionally graded interface. However, at local scale, a...
5.
Thevin P, Curti C, Benech A, Jean C, Lamy E, Castera Ducros C, et al.
PLoS One . 2023 Feb; 18(2):e0282164. PMID: 36827282
Objective: Erythromycin is a macrolide antibiotic that is also prescribed off-label in premature neonates as a prokinetic agent. There is no oral formulation with dosage and/or excipients adapted for these...
6.
Primas N, Lano G, Brun D, Curti C, Sallee M, Sampol-Manos E, et al.
Pharmaceuticals (Basel) . 2023 Jan; 16(1). PMID: 36678569
Parenteral N-acetylcysteine has a wide variety of clinical applications, but its use can be limited by a poor chemical stability. We managed to control parenteral N-acetylcysteine stability, and to study...
7.
Wasilewski M, Curti C, Panuccio C, Bouguergour C, Primas N, Lamy E, et al.
J Pediatr Pharmacol Ther . 2022 Oct; 27(7):625-631. PMID: 36186250
Objective: Clonidine hydrochloride is an antihypertensive, centrally acting α2 adrenergic agonist with various pediatric indications. For pediatric patients, 20-mcg clonidine hydrochloride capsules can be compounded from commercial tablets or from...
8.
Camy C, Brioche T, Senni K, Bertaud A, Genovesio C, Lamy E, et al.
FASEB J . 2022 Sep; 36(10):e22548. PMID: 36121701
While muscle and bone adaptations to deconditioning have been widely described, few studies have focused on the tendon enthesis. Our study examined the effects of mechanical loading on the structure...
9.
Brandin T, Wasilewski M, Panuccio C, Bouguergour C, Primas N, Lamy E, et al.
Int J Pharm Compd . 2022 Apr; 26(2):150-154. PMID: 35413013
Fludrocortisone acetate is a drug used to treat adrenal insufficiencies which can be prescribed to hospitalized or ambulatory pediatric patients at dosages not commercially available. For these patients, 10-µg fludrocortisone...
10.
Wasilewski M, Curti C, Bouguergour C, Panuccio C, Thevin P, Primas N, et al.
Eur J Hosp Pharm . 2022 Feb; 30(6):363-366. PMID: 35105603
Objective: Capsule compounding is common for paediatric patients. In Europe, pharmacists often use a volume-based method whereas, in the USA, the weight-based method prevails. These two methods should be compared...